Overview
What It Is The RNS System is an implanted, closed-loop device that continuously monitors brain activity and delivers targeted electrical stimulation only when it detects abnormal patterns that may lead to a seizure. Electrodes and a cranially placed neurostimulator are surgically implanted; the system is programmed and refined over months and years.
How It Works By stopping abnormal activity early and repeatedly, responsive stimulation can reduce seizures and, over time, contribute to beneficial reorganization of epileptic networks. Long-term outcome studies show that benefits often continue to increase over years—consistent with gradual network plasticity under closed-loop control.
Conditions - FDA-approved: drug-resistant focal epilepsy in appropriately selected patients. - Note: Strong evidence for progressive seizure reduction. Surgical risks apply. Typically covered when eligibility criteria are met.
How it is administered
Surgically implanted device. Electrodes and a cranially placed neurostimulator are implanted; the system is then programmed and adjusted over subsequent months and years with ongoing data review.
Conditions connected in the NPA database
The NPA Treatment Database lists this treatment in connection with 1 condition record. A database relationship does not establish effectiveness, safety, or suitability for an individual.
Related questions
These controlled question pages reference this treatment through stored condition relationships.
Symptoms connected in the NPA database
The current record associates this treatment with the following symptom information. This is not a claim that the treatment will improve these symptoms.
Cognition & Memory
- concentration issues
- Confusion or memory gaps after seizures
Sensory & Pain
- Sensory auras (tingling, unusual sensations)
Practical information
Insurance coverage
Typically covered by insurance for eligible patients with drug-resistant focal epilepsy when criteria are met (prior authorization common).
Cost information
High – device + surgery + programming often tens of thousands of dollars before insurance.
Results and outcomes described in the source record
Some patients notice fewer seizures within months; benefits often continue to improve over 1–5+ years as network changes accumulate.
Side effects and risks
Surgical risks (infection, bleeding, device complications). Stimulation-related side effects are generally mild.
Research context in the NPA database
This section reproduces the current database's research summary and detail. Structured citation metadata has not been supplied, so it should not be read as an independently verified literature review.
Research summary
Evidence Level: Strong (for drug-resistant focal epilepsy)
What the research shows: Long-term studies show that this implanted closed-loop device can progressively reduce seizures in people with drug-resistant focal epilepsy, with benefits that often continue to grow over years.
Key takeaway: An established surgical option for people whose focal seizures have not responded adequately to medication.
Research detail
Overview The RNS System is an implanted, closed-loop device that continuously monitors brain activity and delivers targeted electrical stimulation only when it detects abnormal patterns that may lead to a seizure. Over time the responsive stimulation can contribute to beneficial reorganization of epileptic networks. Electrodes and a cranially placed neurostimulator are surgically implanted; the system is then programmed and refined over subsequent months and years. Patients and clinicians can review recorded data to guide adjustments.
Evidence Base and Published Work • Pivotal trials leading to FDA approval and long-term outcome studies show progressive seizure reduction in many people with drug-resistant focal epilepsy. Benefits often continue to improve over 1–5+ years as network changes accumulate. • Systematic reviews of responsive neurostimulation for epilepsy confirm the findings. • Key published work includes: – Pivotal trials leading to FDA approval. – Long-term outcome studies showing progressive seizure reduction. – Systematic reviews of responsive neurostimulation for epilepsy. – Surgical risks (infection, bleeding, device complications) apply; stimulation-related side effects are generally mild. The device is typically covered when eligibility criteria are met. Evidence is strong for drug-resistant focal epilepsy.
Outcomes Outcomes most frequently described include progressive seizure reduction in many people with drug-resistant focal epilepsy, with benefits that often continue to grow over years. Evidence is strong for this indication.
Questions to ask a provider
1. Do I meet criteria for the RNS System for drug-resistant focal epilepsy? 2. What does the surgical implantation involve, and what are the key surgical and device-related risks? 3. What seizure reduction has been seen long-term in patients with seizure profiles like mine? 4. How is the device programmed and adjusted over months and years? 5. Is RNS covered by my insurance when eligibility criteria are met, and what prior authorization is required?
Website and contact information
Explore the interactive Treatment Database
Continue to compare educational treatment information in the interactive database. The standard disclaimer acknowledgement is required before the database opens.
Explore treatment information in the database